ニュース
SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company led oral and poster presentations of clinical and preclinical ...
Live webcasts and recordings of these presentations will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com.
Management will participate in a fireside chat on Wednesday, June 4, 2025, at 3:10 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, ...
Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company’s product ...
The virtual KOL event will take place on Tuesday, June 3, 2025 at 3:00pm ET. A live question and answer session will follow the discussion.
The 2024 report was prepared in reference to the Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB) and Greenhouse Gas Protocol frameworks and maps selected ...
The 2024 report was prepared in reference to the Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB) and Greenhouse Gas Protocol frameworks and maps selected ...
Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 1, 2025. The Company also reminds those who have previously voted ...
Based on a review of both companies’ financial statements and pro forma projections, the Panel has granted XAGE an exception to allow the Company time to complete its merger with 20/20 and to ...
The cost of ignoring employee stress is high—from absenteeism to quiet quitting and turnover. Proactive support, on the other ...
OSE Immunotherapeutics, chef de file d’un consortium français aux côtés d’Inside Therapeutics et du laboratoire MiNT (Université d’Angers), obtient un financement de 1,3 million d’euros de Bpifrance ...
Pyzchiva® is a key biosimilar value driver for the Sandoz growth strategy. It has been launched in 23 markets in Europe. The autoinjector is now available in Spain and will continue to roll out across ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する